IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Andrews, A.
Right arrow Articles by Kazlauskas, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Andrews, A.
Right arrow Articles by Kazlauskas, A.
(Investigative Ophthalmology and Visual Science. 1999;40:2683-2689.)
© 1999 by The Association for Research in Vision and Ophthalmology, Inc.

Platelet-Derived Growth Factor Plays a Key Role in Proliferative Vitreoretinopathy

Anthony Andrews1, Egle Balciunaite2, Fee Lai Leong2, Michelle Tallquist3, Philippe Soriano3, Miguel Refojo2 and Andrius Kazlauskas2

From 1 Retina Associates, Boston, Massachusetts; and 2 Schepens Eye Research Institute, Harvard Medical School, Boston, Massachusetts; and the 3 Fred Hutchinson Cancer Research Center, Seattle, Washington.

PURPOSE. The action of growth factors is thought to make a substantial contribution to the events leading to proliferative vitreoretinopathy (PVR). In this study, the importance of platelet-derived growth factor (PDGF) was tested in a rabbit model of PVR.

METHODS. The approach was to compare the extent of PVR induced by cells that do or do not express the receptors for PDGF and therefore differ in their ability to respond to PDGF.

RESULTS. Mouse embryo fibroblasts derived from PDGF receptor knock-out embryos that do not express either of the two PDGF receptors induced PVR poorly when injected into the eyes of rabbits that had previously undergone gas vitrectomy. Re-expression of the PDGF ß receptor in these cells did not improve the ability of the cells to cause PVR. In contrast, injection of cells expressing the PDGF {alpha} receptor resulted in stage 3 or higher PVR in 8 of 10 animals.

CONCLUSIONS. These findings show that PDGF makes an important contribution to the development of PVR in this animal model. Furthermore, there is a marked difference between the two receptors for PDGF, and it is the PDGF {alpha} receptor that is capable of driving events that lead to PVR.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Yang, S. Yuzawa, and J. Schlessinger
Contacts between membrane proximal regions of the PDGF receptor ectodomain are required for receptor activation but not for receptor dimerization
PNAS, June 3, 2008; 105(22): 7681 - 7686.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
H. Lei, G. Velez, P. Hovland, T. Hirose, and A. Kazlauskas
Plasmin Is the Major Protease Responsible for Processing PDGF-C in the Vitreous of Patients with Proliferative Vitreoretinopathy
Invest. Ophthalmol. Vis. Sci., January 1, 2008; 49(1): 42 - 48.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
R. Li, A. Maminishkis, F. E. Wang, and S. S. Miller
PDGF-C and -D Induced Proliferation/Migration of Human RPE Is Abolished by Inflammatory Cytokines
Invest. Ophthalmol. Vis. Sci., December 1, 2007; 48(12): 5722 - 5732.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
H. Lei, P. Hovland, G. Velez, A. Haran, D. Gilbertson, T. Hirose, and A. Kazlauskas
A Potential Role for PDGF-C in Experimental and Clinical Proliferative Vitreoretinopathy
Invest. Ophthalmol. Vis. Sci., May 1, 2007; 48(5): 2335 - 2342.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
H.-J. Chen and Z.-Z. Ma
N-Cadherin Expression in a Rat Model of Retinal Detachment and Reattachment
Invest. Ophthalmol. Vis. Sci., April 1, 2007; 48(4): 1832 - 1838.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
S. Svegliati Baroni, M. Santillo, F. Bevilacqua, M. Luchetti, T. Spadoni, M. Mancini, P. Fraticelli, P. Sambo, A. Funaro, A. Kazlauskas, et al.
Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis.
N. Engl. J. Med., June 22, 2006; 354(25): 2667 - 2676.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
M. Weick, P. Wiedemann, A. Reichenbach, and A. Bringmann
Resensitization of P2Y Receptors by Growth Factor-Mediated Activation of the Phosphatidylinositol-3 Kinase in Retinal Glial Cells
Invest. Ophthalmol. Vis. Sci., April 1, 2005; 46(4): 1525 - 1532.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
M. F. James, R. L. Beauchamp, N. Manchanda, A. Kazlauskas, and V. Ramesh
A NHERF binding site links the {beta}PDGFR to the cytoskeleton and regulates cell spreading and migration
J. Cell Sci., June 15, 2004; 117(14): 2951 - 2961.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
J Troger, S Sellemond, G Kieselbach, M Kralinger, E Schmid, B Teuchner, Q A Nguyen, E Schretter-Irschick, and W Gottinger
Inhibitory effect of certain neuropeptides on the proliferation of human retinal pigment epithelial cells
Br. J. Ophthalmol., November 1, 2003; 87(11): 1403 - 1408.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
R. V. Hoch and P. Soriano
Roles of PDGF in animal development
Development, October 15, 2003; 130(20): 4769 - 4784.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
Y. Saishin, Y. Saishin, K. Takahashi, M.-S. Seo, M. Melia, and P. A. Campochiaro
The Kinase Inhibitor PKC412 Suppresses Epiretinal Membrane Formation and Retinal Detachment in Mice with Proliferative Retinopathies
Invest. Ophthalmol. Vis. Sci., August 1, 2003; 44(8): 3656 - 3662.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
I. Milenkovic, M. Weick, P. Wiedemann, A. Reichenbach, and A. Bringmann
P2Y Receptor-Mediated Stimulation of Muller Glial Cell DNA Synthesis: Dependence on EGF and PDGF Receptor Transactivation
Invest. Ophthalmol. Vis. Sci., March 1, 2003; 44(3): 1211 - 1220.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
E. H. Van Aken, O. De Wever, L. Van Hoorde, E. Bruyneel, J.-J. De Laey, and M. M. Mareel
Invasion of Retinal Pigment Epithelial Cells: N-cadherin, Hepatocyte Growth Factor, and Focal Adhesion Kinase
Invest. Ophthalmol. Vis. Sci., February 1, 2003; 44(2): 463 - 472.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
Y. Ikuno and A. Kazlauskas
An In Vivo Gene Therapy Approach for Experimental Proliferative Vitreoretinopathy Using the Truncated Platelet-Derived Growth Factor {alpha} Receptor
Invest. Ophthalmol. Vis. Sci., July 1, 2002; 43(7): 2406 - 2411.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
Y. Ikuno, F.-L. Leong, and A. Kazlauskas
PI3K and PLC{gamma} Play a Central Role in Experimental PVR
Invest. Ophthalmol. Vis. Sci., February 1, 2002; 43(2): 483 - 489.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
Y. Ikuno and A. Kazlauskas
TGF{beta}1-Dependent Contraction of Fibroblasts Is Mediated by the PDGF{alpha} Receptor
Invest. Ophthalmol. Vis. Sci., January 1, 2002; 43(1): 41 - 46.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
T. A. Drixler, I. H. M. B. Rinkes, E. D. Ritchie, F. W. Treffers, T. J. M. V. van Vroonhoven, M. F. B. G. Gebbink, and E. E. Voest
Angiostatin Inhibits Pathological but Not Physiological Retinal Angiogenesis
Invest. Ophthalmol. Vis. Sci., December 1, 2001; 42(13): 3325 - 3330.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
Y. Ikuno, F.-L. Leong, and A. Kazlauskas
Attenuation of Experimental Proliferative Vitreoretinopathy by Inhibiting the Platelet-Derived Growth Factor Receptor
Invest. Ophthalmol. Vis. Sci., September 1, 2000; 41(10): 3107 - 3116.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
S. Rosenkranz, Y. Ikuno, F. L. Leong, R. A. Klinghoffer, S. Miyake, H. Band, and A. Kazlauskas
Src Family Kinases Negatively Regulate Platelet-derived Growth Factor alpha Receptor-dependent Signaling and Disease Progression
J. Biol. Chem., March 24, 2000; 275(13): 9620 - 9627.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the Association for Research in Vision and Ophthalmology